David Johnson of Intelsius argues that it was on the back burner, but you can now call it breaking news. Since the introduction of the new GDP guidelines last September, attention has begun to focus on CRT shipments and the requirement to ship within label conditions. CRT shipments that were shipped unmonitored and in uncontrolled packaging are now creating tension, as the need to demonstrate temperature compliance uncovers a hidden world of issues.
https://international-pharma.com/wp-content/uploads/2014/03/Where-does…pdf.pdf